These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The value of BZ 55 in control of diabetes. MURRAY I; WANG I Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512 [No Abstract] [Full Text] [Related]
3. Clinical trial of the new oral hypoglycaemic agent BZ 55. HUNT JA; OAKLEY W; LAWRENCE RD Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509 [No Abstract] [Full Text] [Related]
4. BZ 55 and D 860 in the treatment of diabetes mellitus. SCHNEIDER T; POLITZER WM S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061 [No Abstract] [Full Text] [Related]
5. Hypoglycaemic sulphonamides in treatment of diabetes. WALKER G; LEESE WL; NABARRO JD Br Med J; 1956 Aug; 2(4990):451-2. PubMed ID: 13342511 [No Abstract] [Full Text] [Related]
6. [Diabetes mellitus, BZ 55, D 860, and glucagon]. RECKNAGEL K Medizinische; 1956 Nov; 1(46):1633-9. PubMed ID: 13386740 [No Abstract] [Full Text] [Related]
7. Trial of an oral hypoglycaemic agent in diabetes. WOLFF FW; STEWART GA; CROWLEY MF; BLOOM A Br Med J; 1956 Aug; 2(4990):440-5. PubMed ID: 13342508 [No Abstract] [Full Text] [Related]
20. Current status of aryl sulfonylureas in treatment of diabetes mellitus. DAVIDSON JW; UNGER RH J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329 [No Abstract] [Full Text] [Related] [Next] [New Search]